Literature DB >> 33471975

Which Genes for Hereditary Breast Cancer?

Steven A Narod1.   

Abstract

Entities:  

Year:  2021        PMID： 33471975     DOI： 10.1056/NEJMe2035083

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects.

Authors:  Kojo Agyemang; Allan M Johansen; Grayson W Barker; Michael J Pennison; Kimberly Sheffield; Hugo Jimenez; Carl Blackman; Sambad Sharma; Patrick A Fordjour; Ravi Singh; Katherine L Cook; Hui-Kuan Lin; Wei Zhang; Hui-Wen Lo; Kounosuke Watabe; Peiqing Sun; Carl D Langefeld; Boris Pasche
Journal:  NPJ Breast Cancer       Date:  2022-07-19

Review 2.  Addressing the routine failure to clinically identify monogenic cases of common disease.

Authors:  Michael F Murray; Muin J Khoury; Noura S Abul-Husn
Journal:  Genome Med       Date:  2022-06-07       Impact factor: 15.266

3.  Lift the Veil of Breast Cancers Using 4 or Fewer Critical Genes.

Authors:  Zhengjun Zhang
Journal:  Cancer Inform       Date:  2022-02-14

4.  A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1/2 gene alteration: "So many little, little traumas could have been avoided".

Authors:  Nikolett Zsuzsanna Warner; AnnMarie Groarke
Journal:  BMC Health Serv Res       Date:  2022-08-06       Impact factor: 2.908

5.  Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.

Authors:  Alberto Valenzuela-Palomo; Elena Bueno-Martínez; Lara Sanoguera-Miralles; Víctor Lorca; Eugenia Fraile-Bethencourt; Ada Esteban-Sánchez; Susana Gómez-Barrero; Sara Carvalho; Jamie Allen; Alicia García-Álvarez; Pedro Pérez-Segura; Leila Dorling; Douglas F Easton; Peter Devilee; Maaike Pg Vreeswijk; Miguel de la Hoya; Eladio A Velasco
Journal:  J Pathol       Date:  2021-12-28       Impact factor: 9.883

6.  Risk Factors for Chemotherapy-Induced Peripheral Neuropathy Caused by Nanoparticle Albumin-Bound Paclitaxel in Advanced Breast Cancer.

Authors:  Qie Guo; Haonan Zhang; Xiao Li; Xianghua Quan
Journal:  Biomed Res Int       Date:  2022-09-13       Impact factor: 3.246

7.  Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants.

Authors:  Ana Carolina Leite Vieira Costa Gifoni; Markus Andret Cavalcante Gifoni; Camila Martins Wotroba; Edenir Inez Palmero; Eduardo Leite Vieira Costa; Wellington Dos Santos; Maria Isabel Achatz
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

8.  Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants.

Authors:  Elena Bueno-Martínez; Lara Sanoguera-Miralles; Alberto Valenzuela-Palomo; Ada Esteban-Sánchez; Víctor Lorca; Inés Llinares-Burguet; Jamie Allen; Alicia García-Álvarez; Pedro Pérez-Segura; Mercedes Durán; Douglas F Easton; Peter Devilee; Maaike Pg Vreeswijk; Miguel de la Hoya; Eladio A Velasco-Sampedro
Journal:  J Pathol       Date:  2022-07-15       Impact factor: 9.883

9.  "You Always Have It in the Back of Your Mind"-Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview Study.

Authors:  Claudia Stracke; Clarissa Lemmen; Kerstin Rhiem; Rita Schmutzler; Sibylle Kautz-Freimuth; Stephanie Stock
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.